StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.73−0.01 (-0.87%)

Close on Nov 19, 2026Market cap $248.50MP/E –Yield –

Ocugen gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2019Jun 30, 2019$0–
Q1 FY2019Mar 31, 2019-$900.00K–

More Ocugen figures

See a number that looks wrong?